Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Shetzline Michael | CMO,SVP,Head-Res&Drug | Mar 08 '24 | Option Exercise | 0.00 | 34,936 | 0 | 429,847 | Mar 12 04:05 PM | John Minardo | Chief Legal Officer | Mar 08 '24 | Option Exercise | 0.00 | 32,752 | 0 | 311,975 | Mar 12 04:05 PM | MCCOURT Thomas A | Chief Executive Officer | Mar 08 '24 | Option Exercise | 0.00 | 120,298 | 0 | 1,217,948 | Mar 12 04:05 PM | Davis Andrew | SVP, Chief Business Officer | Mar 08 '24 | Option Exercise | 0.00 | 37,120 | 0 | 310,756 | Mar 12 04:05 PM | Emany Sravan Kumar | SVP, Chief Financial Officer | Mar 08 '24 | Option Exercise | 0.00 | 37,120 | 0 | 338,853 | Mar 12 04:05 PM | Duane Jon R | Director | Mar 06 '24 | Buy | 8.70 | 6,920 | 60,204 | 121,028 | Mar 08 04:05 PM | Emany Sravan Kumar | SVP, Chief Financial Officer | Mar 04 '24 | Buy | 9.38 | 10,684 | 100,216 | 301,733 | Mar 06 04:05 PM | MCCOURT Thomas A | Chief Executive Officer | Feb 12 '24 | Sale | 15.24 | 177,164 | 2,699,979 | 832,774 | Feb 14 08:35 PM | John Minardo | Chief Legal Officer | Feb 12 '24 | Sale | 15.24 | 47,380 | 722,071 | 224,796 | Feb 14 09:01 PM | Shetzline Michael | CMO,SVP,Head-Res&Drug | Feb 12 '24 | Sale | 15.24 | 38,618 | 588,538 | 340,484 | Feb 14 08:53 PM | Davis Andrew | SVP, Chief Business Officer | Feb 12 '24 | Sale | 15.24 | 9,846 | 150,053 | 208,324 | Feb 14 08:42 PM | Silver Ronald | Principal Accounting Officer | Feb 12 '24 | Sale | 15.24 | 7,908 | 120,518 | 134,264 | Feb 14 08:50 PM | Kessler Marla L | Director | Dec 14 '23 | Sale | 11.19 | 9,926 | 111,072 | 96,572 | Dec 18 04:09 PM | Davis Andrew | SVP, Chief Business Officer | Nov 20 '23 | Sale | 9.69 | 3,287 | 31,851 | 217,374 | Nov 22 04:05 PM | Emany Sravan Kumar | SVP, Chief Financial Officer | Sep 15 '23 | Buy | 8.32 | 36,072 | 300,119 | 188,730 | Sep 18 05:07 PM | John Minardo | Chief Legal Officer | Aug 14 '23 | Sale | 10.04 | 7,045 | 70,732 | 192,195 | Aug 16 04:20 PM | Silver Ronald | Principal Accounting Officer | Aug 14 '23 | Sale | 10.04 | 1,976 | 19,839 | 134,172 | Aug 16 04:21 PM | MCCOURT Thomas A | Chief Executive Officer | May 30 '23 | Sale | 10.70 | 26,632 | 284,962 | 758,284 | Jun 01 05:45 PM | MCCOURT Thomas A | Chief Executive Officer | May 22 '23 | Sale | 10.12 | 36,000 | 364,320 | 784,916 | May 24 04:05 PM | Shetzline Michael | CMO,SVP,Head-Res&Drug | May 22 '23 | Sale | 10.12 | 10,324 | 104,479 | 321,131 | May 24 04:05 PM | Davis Andrew | SVP, Chief Business Officer | May 22 '23 | Sale | 10.12 | 6,305 | 63,807 | 219,327 | May 24 04:05 PM |
|